Nanoengineered STING agonists for cancer therapy: toward immunodynamic control
- DOI
- 10.1186/s13045-026-01860-0
- Published
- 2026-10-20
- Container
- Journal of Hematology & Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13045-026-01860-0,
title = {Nanoengineered STING agonists for cancer therapy: toward immunodynamic control},
author = {Naimeng Liu and Xiangyu Wang and Wenxiang Zhang and Yonemori Kan and Baranova Madina Petrovna and Zhongzhao Wang and Xiangyi Kong and Jing Wang},
year = {2026},
journal = {Journal of Hematology \& Oncology},
doi = {10.1186/s13045-026-01860-0},
url = {https://doi.org/10.1186/s13045-026-01860-0}
}RIS
TY - JOUR TI - Nanoengineered STING agonists for cancer therapy: toward immunodynamic control AU - Naimeng Liu AU - Xiangyu Wang AU - Wenxiang Zhang AU - Yonemori Kan AU - Baranova Madina Petrovna AU - Zhongzhao Wang AU - Xiangyi Kong AU - Jing Wang PY - 2026 JO - Journal of Hematology & Oncology DO - 10.1186/s13045-026-01860-0 UR - https://doi.org/10.1186/s13045-026-01860-0 ER -
APA
Liu, N., Wang, X., Zhang, W., Kan, Y., Petrovna, B. M., Wang, Z., Kong, X., & Wang, J. (2026). Nanoengineered STING agonists for cancer therapy: toward immunodynamic control. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-026-01860-0
Source records
- crossref · retrieved 2026-11-10T14:53:53.929Z